ByHeart Appoints Amy Schulman as Chair of the Board of Directors, Further Solidifying its Position as a Leader in the Infant Nutrition Category
Retrieved on:
Tuesday, March 5, 2024
International Advisory Council, Love, Alnylam Pharmaceuticals, Doctor of Philosophy, Food safety, MD, Health, Female, Polaris Partners, Parent, Mount Sinai Hospital, Mullane, Food, Entrepreneurship, Quality control, Action Against Hunger, Safety, Chairperson, Infant, Family, Biomedical sciences, Hunger, Science, Chair, Harvard Business School, Polaris, Target, Management
NEW YORK, March 5, 2024 /PRNewswire/ --Today, ByHeart, the next-generation baby nutrition company, announced the appointment of Amy Schulman, managing partner at Polaris partners, as Chair of the Board. A stalwart supporter of ByHeart since its inception, Schulman's designation signifies a pivotal moment for the company as it experiences momentous growth and solidifies its position as an industry leader.
Key Points:
- "Amy's insights and passion for health innovation and social impact align with ByHeart's mission," said ByHeart Co-Founder and CEO Ron Belldegrun.
- "We chose Amy as the Chair because of her extensive track record in life sciences and infant nutrition.
- "I have been a staunch supporter of ByHeart from its early days, and I am honored to now chair their board," said Schulman.
- ByHeart remains dedicated to advancing infant nutrition through science, innovation and a commitment to excellence.